Ipamorelin is a selective growth hormone secretagogue (GHS) and ghrelin receptor (GHS-R1a) agonist that stimulates the release of growth hormone (GH) without significantly affecting levels of cortisol or prolactin. It is a pentapeptide designed to mimic ghrelin’s GH-releasing effects but with greater selectivity and fewer side effects.
Clinical studies support Ipamorelin’s efficacy in promoting GH release. In a Phase I human trial (Journal of Clinical Endocrinology & Metabolism, 2004), intravenous administration of Ipamorelin significantly elevated GH levels in healthy adults, demonstrating a dose-dependent effect without significantly altering cortisol levels.
- Product Name: Ipamorelin
- Molecular Formula: C38H49N9O5
- Molecular Weight: 711.87 g/mol
- CAS Number: 170851-70-4
- Unit weight: 2mg
- Form: Lyophilised Solid
USAGE AND STORAGE
Ipamorelin is supplied as a lyophilised solid to ensure maximum stability and ease of use in research environments. For optimal results store out of direct sunlight between 2-8 C° both before and after reconstitution. When reconstituting we recommend XL Peptides approved Bacteriostatic mixing water. When reconstituting ensure the peptide and mixing solution are at room temperature to prevent temperature shock and aid proper dilution.
SYNTHESIS AND QUALITY ASSURANCE
This peptide is meticulously synthesised through a controlled process that ensures high purity, making it suitable for advanced scientific studies. Our commitment to excellence guarantees that each batch undergoes stringent quality control.
